Tom Ransohoff

Tom Ransohoff, Strategic Advisor, has over twenty years in the biopharmaceutical industry, in areas ranging from product and technology development to cGMP manufacturing. In addition to his previous leadership roles at Tarpon Biosystems and at BioFlash Partners LLC wher he served as CEO, Mr. Ransohoff is a Senior Consultant with Bioprocess Technology Consultants, a leading biopharmaceutical CMC consulting firm. Mr. Ransohoff's previous experience includes senior positions with business unit and operational responsibility at TranXenoGen, Dyax, Repligen, and Xoma. Mr. Ransohoff has a Bachelor's degree from MIT and a Master's degree from UC-Berkeley, both in Chemical Engineering.